HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yngvar Fløisand Selected Research
Yngvar Fløisand Research Topics
Disease
9
Neoplasms (Cancer)
05/2024 - 03/2007
7
Graft vs Host Disease (Graft-Versus-Host Disease)
10/2021 - 01/2010
4
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 10/2018
4
Leukemia
01/2023 - 05/2008
2
Lymphoma (Lymphomas)
05/2024 - 01/2018
2
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 07/2019
2
Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 01/2018
2
Infections
01/2019 - 09/2014
1
GATA2 Deficiency
01/2022
1
Crohn Disease (Crohn's Disease)
10/2021
1
Ulcerative Colitis
10/2021
1
Bronchiolitis Obliterans Syndrome
01/2021
1
Atherosclerosis
01/2021
1
Lymphoid Leukemia
01/2021
1
Atherosclerotic Plaque (Atheroma)
01/2021
1
Myeloid Leukemia (Leukemia, Myelocytic)
07/2019
1
Hemolysis
01/2019
1
Thromboinflammation
01/2019
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2018
1
Drug-Related Side Effects and Adverse Reactions
08/2015
1
Cytopenia
01/2014
1
Bronchiolitis Obliterans
08/2013
1
Osteoarthritis
01/2013
1
Pathologic Processes
02/2011
1
Hyperoxia
02/2011
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2010
1
Hematologic Diseases (Blood Diseases)
01/2010
1
Opportunistic Infections (Opportunistic Infection)
01/2010
1
T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)
03/2004
1
Herpes Zoster
03/2004
1
Chickenpox
03/2004
Drug/Important Bio-Agent (IBA)
3
Steroids
IBA
10/2021 - 01/2017
3
vedolizumab
IBA
10/2021 - 01/2017
2
RNA (Ribonucleic Acid)
IBA
01/2023 - 01/2021
1
Cytokines
IBA
05/2024
1
Chimeric Antigen Receptors
IBA
05/2024
1
Vaccines
IBA
01/2023
1
Antigens
IBA
01/2023
1
Lipids
IBA
01/2021
1
Phosphotransferases (Kinase)
IBA
01/2021
1
Thomsen-Friedenreich antibodies
IBA
01/2021
1
Globulins
IBA
01/2021
1
Messenger RNA (mRNA)
IBA
01/2021
1
Apolipoproteins E (ApoE)
IBA
01/2021
1
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
01/2021
1
DNA Glycosylases (DNA Glycosylase)
IBA
01/2021
1
Tyrosine Kinase Inhibitors
IBA
01/2021
1
Peptides (Polypeptides)
IBA
07/2019
1
Prothrombin (Factor II)
IBA
01/2019
1
Complement System Proteins (Complement)
IBA
01/2019
1
Haptoglobins
IBA
01/2019
1
Heme (Haem)
IBA
01/2019
1
Hemopexin
IBA
01/2019
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
10/2018
1
Proteins (Proteins, Gene)
FDA Link
10/2018
1
Antibodies
IBA
01/2018
1
Immunoglobulin G (IgG)
IBA
01/2018
1
Immunoglobulin Fragments
IBA
01/2018
1
Rituximab (Mabthera)
FDA Link
01/2018
1
Single-Chain Antibodies
IBA
01/2018
1
Integrins
IBA
01/2017
1
Glutathione Transferase (Glutathione S-Transferase)
IBA
08/2015
1
eltrombopag
FDA Link
01/2014
1
Thrombopoietin Receptors
IBA
01/2014
1
Carbon Dioxide
IBA
02/2011
1
Galectins (Galectin)
IBA
02/2011
1
Galectin 1 (LGALS1)
IBA
02/2011
1
Oxygen (Dioxygen)
IBA
02/2011
1
Tretinoin (Retinoic Acid)
FDA Link
Generic
05/2008
1
Toll-Like Receptor Agonists
IBA
10/2007
1
Alemtuzumab (Campath)
FDA Link
03/2004
1
Antiviral Agents (Antivirals)
IBA
03/2004
Therapy/Procedure
5
Hematopoietic Stem Cell Transplantation
01/2023 - 01/2010
4
Stem Cell Transplantation
01/2021 - 03/2007
3
Drug Therapy (Chemotherapy)
01/2023 - 05/2008
2
Induction Chemotherapy
01/2023 - 01/2023
2
Cell Transplantation
10/2021 - 01/2019
2
Transplantation
09/2014 - 01/2010
2
Therapeutics
01/2013 - 02/2011
1
Traction
12/2023
1
Intravenous Injections
01/2018
1
Lung Transplantation
08/2013